CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

About Us
Data

News & Events

Recent Publications

Bridging the gap: aligning economic research with disease burden

BMJ Global Health

Do LA, Synnott PG, Ma S, Ollendorf DA. Bridging the gap: aligning economic research with disease burden. BMJ Global Health 2021;6(6).

Value‐based drug pricing in the Biden era: Opportunities and prospects

Health Services Research

Neumann PJ, Ollendorf DA, Cohen JT. Value‐based drug pricing in the Biden era: Opportunities and prospects. Health Services Research 2021.

External reference pricing: The drug-pricing reform America needs?

The Commonwealth Fund Issues Brief

Ollendorf DA, Synnott PG, Neumann PJ. "External reference pricing: The drug-pricing reform America needs?," The Commonwealth Fund Issues Brief, May 27, 2021.

A next frontier in health care transparency: payer drug coverage policy

Health Affairs Blog

Chambers JD, Neumann PJ. "A next frontier in health care transparency: payer drug coverage policy," Health Affairs Blog, April 7, 2021.

An evidence review of low-value care recommendations: Inconsistency and lack of economic evidence considered

Journal Of General Internal Medicine

Kim DD, Do LA, Daly AT, Wong JB, Chambers JD, Ollendorf DA, Neumann PJ. An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence Considered. J Gen Intern Med. 2021 Feb 23.

Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained

Acta Diabetologica

Olchanski N, van Klaveren D, Cohen JT, Wong JB, Ruthazer R, Kent DM. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained. Acta Diabetologica 2021.

Shared decision making during initial diagnostic and treatment planning visits for children with autism spectrum disorder

Journal of Developmental and Behavioral Pediatrics

Mulé CM, Lavelle TA, Sliwinski SK, Wong JB. Shared Decision-Making During Initial Diagnostic and Treatment Planning Visits for Children with Autism Spectrum Disorder. Journal of Developmental & Behavioral Pediatrics 2021.

Eroding progress on evidence and outcomes: CMS’s new proposed pathway for medical device coverage

Health Affairs blog

Neumann PJ, Chambers JD. "Eroding progress on evidence and outcomes: CMS’s new proposed pathway for medical device coverage," Health Affairs Blog, December 2, 2020.

International reference pricing: A lazy, misguided, bi-partisan plan to lower US drug prices

Health Affairs blog

Basu A, Neumann PJ, Sullivan S. "International reference pricing: A lazy, misguided, bi-partisan plan to lower US drug prices," Health Affairs Blog, December 2, 2020.

Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic

Health Affairs

Neumann PJ, Cohen JT, Kim DD, Ollendorf DA. Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic. Health Affairs 2020;40(1):53–61.

Preparing the health‐care system to pay for new Alzheimer's drugs

Alzheimer's & Dementia

Lin, PJ, Cohen, JT, Neumann, PJ. Preparing the health‐care system to pay for new Alzheimer's drugs. Alzheimer's Dement. 2020; 1– 3.

Measuring “fearonomic effects” in valuing therapies: An application to COVID-19 in China

Value in Health

Ma S, Kim DD, Cohen JT, Neumann PJ. "Measuring “fearonomic effects” in valuing therapies: An application to COVID-19 in China," Value in Health (in press).

Perspective and costing in cost-effectiveness analysis, 1974–2018

PharmacoEconomics

Kim, DD, Silver, MC, Kunst, N, Cohen JT, Ollendorf DA, Neumann PJ. Perspective and costing in cost-effectiveness analysis, 1974–2018. PharmacoEconomics 38, 1135–1145 (2020).

Patient characteristics and treatment patterns among Medicare beneficiaries initiating PCSK9 inhibitor therapy

Cardiovascular Drugs and Therapy

Xue F, Berklein F, Rane PB, Habib M, Lin PJ. "Patient characteristics and treatment patterns among Medicare beneficiaries initiating PCSK9 inhibitor therapy," Cardiovascular Drugs and Therapy, June 27, 2020.

Crisis into opportunity: Can COVID-19 help set a path to improved health care efficiency?

American Journal of Managed Care

Kim DD, Ollendorf DA, Neumann PJ, Fendrick M. "Crisis into opportunity: Can COVID-19 help set a path to improved health care efficiency?,"AJMC Commentary, June 17, 2020.

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.